139 related articles for article (PubMed ID: 4449146)
1. Hypolipidemic effect of a new aryloxy compound, S-8527, in experimental animals.
Suzuki K; Aono S; Nakatani H
Jpn J Pharmacol; 1974 Jun; 24(3):407-14. PubMed ID: 4449146
[No Abstract] [Full Text] [Related]
2. [Therapeutic of acetiromate on hyperlipidemia--comparison with clofibrate using a double-blind method].
Nakano Y; Fukui I; Niiho S; Kuki H; Takahata J
Nihon Rinsho; 1974 Jul; 32(7):2526-51. PubMed ID: 4612204
[No Abstract] [Full Text] [Related]
3. [Hypolipidemic activity of substances structurally close to penphenone in rats and mice].
Polikarpova LI; Reznik SE; Ryzhenkov VV; Khechinashvili GG; Petrova LA
Vopr Med Khim; 1978; 24(6):835-9. PubMed ID: 216145
[TBL] [Abstract][Full Text] [Related]
4. Hypolipidaemic activity of orally administered diphenyl diselenide in Triton WR-1339-induced hyperlipidaemia in mice.
da Rocha JT; Sperança A; Nogueira CW; Zeni G
J Pharm Pharmacol; 2009 Dec; 61(12):1673-9. PubMed ID: 19958591
[TBL] [Abstract][Full Text] [Related]
5. Experimental hyper-beta-lipoproteinemia and its amelioration by a novel hypolipidemic agent.
Kobayakawa T; Osuga K; Yasuda H
Atherosclerosis; 1978 Jul; 30(3):219-25. PubMed ID: 209804
[TBL] [Abstract][Full Text] [Related]
6. The results of animal studies with ciprofibrate, a new orally effective hypolipidemic drug.
Arnold A; McAuliff JP; Powers LG; Phillips DK; Beyler AL
Atherosclerosis; 1979 Feb; 32(2):155-63. PubMed ID: 454514
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of several hypolipidemic agents related to clofibrate.
Beaumont V; Buxtorf JC; Jacotot B; Beaumont JL
Atherosclerosis; 1974; 20(2):141-53. PubMed ID: 4369878
[No Abstract] [Full Text] [Related]
8. Editorial: Lipid-lowering drugs after myocardial infarction.
Lancet; 1975 Mar; 1(7905):501-2. PubMed ID: 46964
[No Abstract] [Full Text] [Related]
9. Treatment of hypertriglyceridemia with tibric acid and clofibrate. Cross-over studies, effects on lipoproteins and absence of post-drug rebound.
Smith FR; Noble RP; Goodman DS
Atherosclerosis; 1978 Mar; 29(3):345-54. PubMed ID: 666884
[No Abstract] [Full Text] [Related]
10. A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias.
Jepson EM; Small E; Grayson MF; Bance G; Billimoria JD
Atherosclerosis; 1972; 16(1):9-14. PubMed ID: 4341723
[No Abstract] [Full Text] [Related]
11. Fundamental studies on physiological and pharmacological actions of L-ascorbate 2-sulfate. I. On the hypolipidemic effects.
Hayashi E; Yamada J; Kunitomo M; Terada M; Tomita T; Kinoshita
J Nutr Sci Vitaminol (Tokyo); 1976; 22(3):201-8. PubMed ID: 966076
[TBL] [Abstract][Full Text] [Related]
12. Clinical and metabolic effects of pentaerythritol tetranicotinate in combination with cholesolvin or clofibrate.
Olsson AG; Orö L; Rössner S
Atherosclerosis; 1974; 19(3):407-15. PubMed ID: 4364073
[No Abstract] [Full Text] [Related]
13. [Hypolipidemic activity of glycine and its derivatives].
Ryzhenkov VE; Molokovskiĭ DS; Ioffe DV
Vopr Med Khim; 1984; 30(2):78-80. PubMed ID: 6740998
[TBL] [Abstract][Full Text] [Related]
14. Effect of KC-9432, a new hypolipidemic compound, on high density lipoprotein cholesterol in rats.
Seri K; Sato R; Hamazaki Y; Yamamoto T; Ishiyama N
Atherosclerosis; 1980 Sep; 37(1):97-102. PubMed ID: 6893550
[TBL] [Abstract][Full Text] [Related]
15. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
Kesäniemi YA; Grundy SM
JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
[TBL] [Abstract][Full Text] [Related]
16. The hypolipidemic effect of SU-13,437 in rats with natural endogenous hypertriglyceridemia.
Lenz PH; Fleischman AI
Lipids; 1971 Nov; 6(11):783-6. PubMed ID: 5127473
[No Abstract] [Full Text] [Related]
17. Comparative hypolipidaemic effectiveness of gum guggulu (Commiphora mukul) fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su.
Malhotra SC; Ahuja MM
Indian J Med Res; 1971 Oct; 59(10):1621-32. PubMed ID: 5159000
[No Abstract] [Full Text] [Related]
18. [The angioprotector and hypolipemic activity of leukomizin in experimental atherosclerosis].
Kirmukov AG; Aĭzikov MI; Rasulova SA; Sidiakin GP; Sham'ianov ID; Malikov VM
Farmakol Toksikol; 1991; 54(3):35-7. PubMed ID: 1915817
[TBL] [Abstract][Full Text] [Related]
19. Studies of the uricosuric action of the hypolipidemic drug halofenate.
Ravenscroft PJ; Sands JM; Emmerson BT
Clin Pharmacol Ther; 1973; 14(4):547-51. PubMed ID: 4723262
[No Abstract] [Full Text] [Related]
20. The hypolipidemic activity of novel benzofuran-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats: a comparison with bezafibrate.
Shattat G; Al-Qirim T; Sweidan K; Shahwan M; El-Huneidi W; Al-Hiari Y
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):751-5. PubMed ID: 20590406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
